Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 16Terminated 4Unknown 3Recruiting 2Withdrawn 1Suspended 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 7Pancreatic Neoplasms 6Brain Neoplasms 6Neoplasms 5Glioma 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Liver Neoplasms 2Glioblastoma 2Disease 2Central Nervous System Neoplasms 2Astrocytoma 2Urinary Bladder Neoplasms 1Soft Tissue Neoplasms 1Recurrence 1Rectal Neoplasms 1Penile Neoplasms 1Pediatric Brain Tumor 1Pancreatic Cyst 1Osteosarcoma 1Nervous System Diseases 1Muscle Weakness 1Metabolic Diseases 1Lymphoma, Non-Hodgkin 1Lymphoma 1Lung Neoplasms 1Inflammatory Breast Neoplasms 1Hodgkin Disease 1

Interventions

Magnetic Resonance Spectroscopy 51Specimen Handling 42enzalutamide 35Androgen Antagonists 34Radiosurgery 32Radiotherapy 31Prednisone 26darolutamide 24Abiraterone Acetate 24Leuprolide 22Docetaxel 22apalutamide 20Pluvicto 19abiraterone 18Standard of Care 18Triptorelin Pamoate 17Radiation 17Biopsy 16relugolix 15acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 15Goserelin 14Blood Specimen Collection 13gallium 68 PSMA-11 12pembrolizumab 11X-Rays 11Surveys and Questionnaires 11luprolide acetate gel depot 10Carboplatin 10Methods 9Interviews as Topic 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Prostatic Neoplasms × Magnetic Resonance Imaging × Clear all
NCT06280781 2026-03-30

IP9-ATLAS

Imperial College London

Phase NA Recruiting
1,263 enrolled
Genitourinary

Prostatic Neoplasms

NCT07249281 2025-11-25

MR Microstructural Imaging for Prostate Cancer Diagnosis

First Affiliated Hospital of Zhejiang University

Recruiting
2,000 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡